Literature DB >> 16644332

Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.

Louis C Coyle1, Antonio Rodriguez, Robert E Jeschke, Anabela Simon-Lee, Kevin C Abbott, Allen J Taylor.   

Abstract

BACKGROUND: Patients with diabetes mellitus (DM) are at increased risk of contrast-associated nephropathy irrespective of their baseline creatinine (Cr). We tested the efficacy of N-acetylcysteine (NAC) relative to hydration in unselected patients (irrespective of baseline Cr) with DM.
METHODS: We conducted a randomized open-label study comparing hydration alone (combined oral and rapid intravenous hydration, n = 69) to NAC plus hydration (similar hydration protocol plus NAC 600 mg BID x 4 doses, n = 68) in diabetic patients (mean age 65 +/- 10 years, 65% men) undergoing elective coronary angiography. The primary end point was the mean change in serum Cr measured up to 96 hours postangiography.
RESULTS: Baseline Cr was 1.14 +/- 0.43 mg/dL (Cr > or = 1.3 mg/dL in 37 subjects). Baseline characteristics including blood urea nitrogen, Cr, and contrast volume were similar between the 2 groups. The mean Cr change in the NAC group was 0.14 +/- 0.47 versus 0.08 +/- 0.11 mg/dL in the hydration only group (P = NS). Contrast-associated nephropathy, defined as a > or = 0.5 mg/dL increase in Cr, was significantly more common in the NAC group, 9.2% versus 1.4%, P = .043. Similar results were found in the subgroup of participants with either an increased baseline serum Cr (> or = 1.3 mg/dL) or in those receiving high contrast volumes (> 100 mL).
CONCLUSIONS: N-Acetylcysteine provides no benefit over an aggressive hydration protocol in patients with DM undergoing coronary angiography.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644332     DOI: 10.1016/j.ahj.2006.02.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

Review 1.  Contrast-induced acute kidney injury: short- and long-term implications.

Authors:  Steven D Weisbord; Paul M Palevsky
Journal:  Semin Nephrol       Date:  2011-05       Impact factor: 5.299

2.  Evaluation of brain and kidney energy metabolism in an animal model of contrast-induced nephropathy.

Authors:  Clarissa A Roza; Giselli Scaini; Isabela C Jeremias; Gabriela K Ferreira; Natalia Rochi; Joana Benedet; Gislaine T Rezin; Francieli Vuolo; Larissa S Constantino; Fabricia C Petronilho; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2011-03-25       Impact factor: 3.584

3.  Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial.

Authors:  Rohit J Timal; Judith Kooiman; Yvo W J Sijpkens; Jean-Paul P M de Vries; Iris J A M Verberk-Jonkers; Harald F H Brulez; Marjolijn van Buren; Aart J van der Molen; Suzanne C Cannegieter; Hein Putter; Wilbert B van den Hout; J Wouter Jukema; Ton J Rabelink; Menno V Huisman
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

4.  N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.

Authors:  Manouchehr Amini; Mojtaba Salarifar; Alireza Amirbaigloo; Farzad Masoudkabir; Fatemeh Esfahani
Journal:  Trials       Date:  2009-06-29       Impact factor: 2.279

5.  Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention.

Authors:  Kun Yang; Wenxian Liu; Wei Ren; Shuzheng Lv
Journal:  Int Urol Nephrol       Date:  2014-06-26       Impact factor: 2.370

Review 6.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

Review 7.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

Review 9.  Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.

Authors:  Michele Andreucci; Richard Solomon; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

10.  A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.

Authors:  Denise A Gonzales; Kelly J Norsworthy; Steven J Kern; Steve Banks; Pamela C Sieving; Robert A Star; Charles Natanson; Robert L Danner
Journal:  BMC Med       Date:  2007-11-14       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.